Targeted Coronary Thrombolysis via “Pericardial” Administration of Lytic Agents?

This publication has 24 references indexed in Scilit:

• Selective Inhibition of Factor Xa Is More Efficient Than Factor VIIa–Tissue Factor Complex Blockade at Facilitating Coronary Thrombolysis in the Canine Model
  JACC, 1996
• Intramyocardial Injections and Protection Against Myocardial Ischemia
  Circulation, 1996
• Adventitia as a target for intravascular local drug delivery.
  Heart, 1996
• Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator
  American Heart Journal, 1996
• Anticoagulant Effects of Low-Molecular-Weight Heparin following Thrombolytic Therapy in Acute Myocardial Infarction: A Dose-Finding Study
  Pathophysiology of Haemostasis and Thrombosis, 1996
• Treatment of exudative fibririous pericarditis with intrapericardial urokinase
  The Lancet, 1994
• Sotalol Controlled-Release Systems for Arrhythmias: In Vitro Characterization, in Vivo Drug Disposition, and Electrophysiologic Effects
  Journal of Pharmaceutical Sciences, 1994
• Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery
  JACC, 1990
• Use of streptokinase to aid in drainage of postoperative pericardial effusion.
  Heart, 1989
• Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
  Circulation Research, 1985